Table 2 Cases of adult-onset Still’s disease (AOSD) after SARS-CoV-2 infection and/or COVID-19 vaccination
Sex | Age (years) | Occurrence of symptoms | Publication | Criteria used for diagnosis | Type of vaccination |
|---|---|---|---|---|---|
Female | 29 | 6 months after the diagnosis of SARS-CoV-2 infection | [11] | Yamaguchi classification | – |
Male | 27 | Recovered from SARS-CoV-2- infection 8 weeks prior | [13] | Yamaguchi classification | – |
Male | 36 | 1 day after first COVID-19 vaccination | [14] | Yamaguchi classification | ChAdOx1 nCoV-19 |
Male | 43 | 10 days after receiving the second dose of the vaccination | [15] | Yamaguchi classification | BNT162b2 mRNA |
Female | 56 | 7 days after receiving the second vaccination | [15] | Yamaguchi classification | BNT162b2 mRNA |
Male | 53 | 8 weeks after COVID-19 vaccination | [16] | Yamaguchi classification | ChAdOx1 nCoV-19/AZD1222 |
Female | 45 | 5 days after the second dose of the COVID-19 vaccination | [17] | Yamaguchi classification | mRNA-1273 COVID-19 vaccine |
Female | 36 | 10 days after the first dose of vaccination | [18] | Yamaguchi classification | BNT162b2 mRNA |